Australia markets closed

Dali Pharmaceuticalco.,Ltd (603963.SS)

Shanghai - Shanghai Delayed price. Currency in CNY
Add to watchlist
4.9700-0.2300 (-4.42%)
At close: 03:00PM CST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
65,703
87,270
132,344
171,493
213,583
Cost of revenue
48,212
50,973
57,786
45,943
58,316
Gross profit
17,491
36,297
74,558
125,550
155,268
Operating expenses
Research development
1,387
839.5236
926.9888
1,441
2,829
Selling general and administrative
29,214
45,008
78,736
120,599
136,723
Total operating expenses
44,884
60,423
96,955
138,781
156,900
Operating income or loss
-27,393
-24,126
-22,397
-13,231
-1,632
Interest expense
1,455
1,709
1,078
247.3453
-
Income before tax
-20,674
-17,368
-16,998
-41,592
3,776
Income tax expense
2,181
2,663
703.9665
298.6976
544.2484
Income from continuing operations
-22,855
-20,031
-17,702
-41,891
3,232
Net income
-22,855
-20,031
-17,702
-41,891
3,232
Net income available to common shareholders
-22,855
-20,031
-17,702
-41,891
3,232
Basic EPS
-0.10
-0.09
-0.08
-0.19
0.01
Diluted EPS
-0.10
-0.09
-0.08
-0.19
0.01
Basic average shares
221,249
222,571
221,269
220,477
323,167
Diluted average shares
221,249
222,571
221,269
220,477
323,167